REG - Eco Animal Health Gp - Director/PDMR Shareholding

ECO Animal HealthAnnouncement

21/04/2021 16:35

RNS Number : 2159W
  
Eco Animal Health Group PLC
  
21 April 2021
  
 

 
 
ECO Animal Health Group plc
(''ECO" or "the Company")
(AIM: EAH)
ECO Animal Health Group announces that Lloyd Smart, a PDMR, has sold 8,000 ordinary shares in the Company at a price of 360 pence per share on 20 April 2021 following an exercise of 8,000 options over ordinary shares under the Company's 2011 Unapproved Staff Share Option Scheme ("USOS").  
 
Contacts: 



 
ECO Animal Health Group plc
Marc Loomes (CEO)
Christopher Wilks (CFO)
 




020 8447 8899
 




IFC Advisory 
Graham Herring 
Zach Cohen
 


020 3934 6630
 




N+1 Singer (Nominated Adviser & Joint Broker)
Mark Taylor
Iqra Amin
 


020 7496 3000




Peel Hunt LLP (Joint Broker)
James Steel
Dr Christopher Golden


020 7418 8900



 
 



 1


Details of the person discharging managerial responsibilities / person closely associated




a)
 
 


Name


Lloyd Smart




2


Reason for the notification




a)
 
 


Position/status


PDMR
 




b)


Initial notification/Amendment


Initial Notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Eco Animal Health Group Plc




b)


LEI


2138009XN9DJ3YP70B55




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument
Identification code
 


Ordinary shares of 5p each
GB0032036807




b)


Nature of transaction


Sale and Exercise of options




c)


Price(s) and volume(s)


Price(s)


Volume(s)












360p


8000








Aggregated information
-      Aggregated volume
-      Price


 
8000
360p




e)


Date of the transaction


20 April 2021




f)


Place of the transaction


AIM 



 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHBUGDSBXDDGBB